Experimental Vaccine for Malaria in Adults in Mali

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 23, 2004

Study Completion Date

January 22, 2008

Conditions
Plasmodium Falciparum Malaria
Interventions
BIOLOGICAL

AMA1-C1

DRUG

AMA1-C1/alhydrogel Malaria Vaccine

Trial Locations (1)

Unknown

Malaria Research and Training Center (MRTC), Bamako

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00343005 - Experimental Vaccine for Malaria in Adults in Mali | Biotech Hunter | Biotech Hunter